Generic CellCept

Although there are generic CellCept (mycophenolate mofetil) capsules and tablets available, there are no generic versions of the liquid suspension or intravenous (IV) injections. The first patent for the injectable form of this medication is set to expire in September 2013, and in November 2014 for the oral liquid suspension. These are the earliest predictable dates that generic versions of these forms might become available.

Can I Buy Generic CellCept?

CellCept® (mycophenolate mofetil) is a prescription anti-rejection medication used in combination with other medicines to prevent organ rejection after a kidney, heart, or liver transplant. It comes in the form of a tablet, a capsule, an oral liquid suspension, and an intravenous (IV) injection.
 
CellCept is made by F. Hoffmann-La Roche, Ltd., and distributed by Genentech USA, Inc. CellCept tablets and capsules are available in generic versions. CellCept IV injection and oral liquid suspension are not yet available as generics.
 

Available Strengths

Generic CellCept is available in the following strengths and forms:
 
  • Mycophenolate mofetil 250 mg capsules
  • Mycophenolate mofetil 500 mg tablets.
 

Who Makes Generic CellCept?

Generic CellCept capsules are made by several different companies, including but not limited to:
 
  • Sandoz
  • Roxane Laboratories, Inc.
  • Zydus Pharmaceuticals USA, Inc.
  • Teva Pharmaceuticals USA.
 
The generic tablets are also made by several companies, such as:
 
  • Roxane Laboratories, Inc.
  • Accord Healthcare, Ltd.
  • Mylan, Inc.
  • Endo Pharmaceuticals.
 
Generic CellCept Article Continues on Next Page >
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD
 
Other Articles in This eMedTV Presentation
Referring Pages Articles